A5093307560- Cardiac electrophysiology and arrhythmias
- Congenital Heart Disease Studies
- Transplantation: Methods and Outcomes
- Cardiovascular Effects of Exercise
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Pharmacological Effects and Toxicity Studies
- Cardiac Imaging and Diagnostics
- Heparin-Induced Thrombocytopenia and Thrombosis
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Infant Development and Preterm Care
- Organ Transplantation Techniques and Outcomes
- Analog and Mixed-Signal Circuit Design
- Neonatal Respiratory Health Research
- Advanced MRI Techniques and Applications
- Neonatal Health and Biochemistry
- Drug Transport and Resistance Mechanisms
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Epilepsy research and treatment
Mayo Clinic in Arizona
2024-2025
Mayo Clinic
2024-2025
WinnMed
2024-2025
Mayo Clinic Hospital
2024
Universidade do Vale do Itajaí
2023
Background. The Fontan procedure has transformed the management of congenital heart defects characterized by single ventricle physiology, yet it predisposes individuals to Fontan-associated liver disease. Combined and transplantation (CHLT) emerges as a therapeutic option, but evidence its efficacy safety remains limited. This study aimed comprehensively evaluate CHLT in patients, focusing on patient characteristics, perioperative outcomes, posttransplant morbidity mortality. Methods....
To develop machine learning tools for automated hypertrophic cardiomyopathy (HCM) case recognition from echocardiographic metrics, aiming to identify HCM standard data with high performance. Four different random forest models were developed using a case-control cohort composed of 5548 patients and 16,973 controls without HCM, January 1, 2004, March 15, 2019. Each patient was matched 3 by sex, age, year echocardiography. Ten-fold crossvalidation used train the HCM. Variables included in...
Abstract Introduction Hypertrophic cardiomyopathy (HCM) is the most prevalent heritable typically transmitted in an autosomal dominant fashion. There growing importance identifying genetic test positive patients given its prognostic value. The Mayo HCM Genotype Predictor Score has been extensively validated for assessment of patient’s pre-test probability genotype and helps guide clinical decision-making based on echocardiographic variables. Herein, we evaluated role cardiac magnetic...
Introduction: Long QT syndrome (LQTS) is a potentially life-threatening genetic heart disease. Patients with LQTS may also have co-existent mental health illnesses that benefit from psychiatric medications. However, because many of these medications QT-prolonging potential (www.crediblemeds.org), patients receive suboptimal care. Objective: To evaluate the frequency, management, and incidence breakthrough cardiac events (BCEs) in concomitant issues treated Methods: A retrospective review was...
Background: The Fontan procedure has transformed the management of congenital heart defects (CHD) characterized by single ventricle physiology, yet it predisposes individuals to Fontan-associated liver disease (FALD), potentially leading end-stage (ESLD). Combined and transplantation (CHLT) emerges as a therapeutic option, but evidence on its efficacy, safety, outcomes remains limited. Objectives: This systematic review single-arm meta-analysis aims comprehensively evaluate literature CHLT...
Background: LQTS is a genetic heart disease associated with an increased risk of sudden death. Despite advances in testing, small subset patients still lacks identifiable markers. Consequently, the true prevalence and clinical phenotype genotype negative remains to be determined. Objective: To determine characteristics diagnosis but test. Methods: A retrospective review was conducted on evaluated treated at tertiary hospital between 2000 2024, focusing those LQTS, test for all...